Department of Veterinary Clinical Medicine
College of Veterinary Medicine
University of Illinois
Urbana, IL 61802
Canine mast cell tumors: How do TK inhibitors fit? (Proceedings)
April 1st 2010One of the most common questions an oncologist hears from a pet owner is, "Why did my dog get cancer?" While it is often impossible to provide a specific answer for a specific patient, our understanding of why cancer develops has grown exponentially in the past decade. As are most things in the living organism, the causes are extremely complex, multifactorial, and still not completely understood.
Read More
Osteosarcoma and hemangiosarcoma: The ugly sarcomas (Proceedings)
April 1st 2010Osteosarcoma (OSA) and hemangiosarcoma (HSA) are highly malignant tumors that have both a locally invasive and highly metastatic biologic behavior. Multimodality therapy must be employed to provide patients with these cancers the best chance for improved quality and quantity of life.
Read More
Canine lymphoma: The naive patient (Proceedings)
April 1st 2010Canine lymphoma (LSA) makes up approximately 18% of all malignancies in the dog, and 80% of all hematopoietic tumors in dogs are LSA. Middle-aged dogs are most commonly affected; but out of cancers affecting young dogs (as young as 6 months), LSA is common.
Read More
Cancer is the easy part! Techniques to help with difficult clients (Proceedings)
April 1st 2010Speaking with pet owners is something veterinarians do constantly; as such, it is the most common "procedure" performed in veterinary medicine. Yet very few veterinarians receive any guidance in this critical area during veterinary school or after.
Read More
Chemotherapy safety: Why, when, and how (Proceedings)
April 1st 2010Chemotherapy safety can be broken down into two big categories: safety for the patient, and safety for the individuals handling the drugs. Understanding how chemotherapy works provides a background for knowing potential dangers of treatments as well as how to safely use these beneficial drugs.
Read More